Ims Sweden

IMS to Present at UBS Conference On September 24 at 12:30 p.m. ET

Pressmeddelande   •   Sep 18, 2008 11:58 CEST

Contact:
Darcie Peck
Investor Relations
(203) 845-5237
dpeck@imshealth.com

NORWALK, CT, September 17, 2008 - IMS Health (NYSE: RX), the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that Darcie Peck, vice president, Investor Relations, will speak to investors and analysts attending the UBS Global Life Sciences Conference, to be held at The Grand Hyatt Hotel in New York City on September 22-25, 2008.

To listen to a live audio Webcast of the IMS presentation on Wednesday, September 24, 2008 at 12:30 p.m. ET, go to http://events.streamx.us/US/event/eventdetails.aspx?id=ubs20080922. A replay of the presentation will be available until October 1, 2008.

About IMS
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.2 billion in 2007 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients' day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.